Normal allele: GG
Estrogen receptor-positive (ER+) breast cancer risk is 1.7 times higher.
Polymorphism rs2981582 is related to topics like this:
Research and publications:
17529967 Genome-wide association study identifies novel breast cancer susceptibility loci.
18224312 Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment
18326623 Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.
18462018 Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
18478591 Studies of genes in the FGF signaling pathway and oral clefts with or without dental anomalies.
18483326 FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.
18535005 The search for genes contributing to endometriosis risk
18681954 Breast cancer susceptibility loci and mammographic density.
18772892 Can genes for mammographic density inform cancer aetiology?
18785201 Novel breast cancer risk alleles and endometrial cancer risk.
18973230 Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.
19005751 Low penetrance breast cancer predisposition SNPs are site specific.
19088016 Genetic susceptibility loci for breast cancer by estrogen receptor status.
19092773 Breast cancer susceptibility: current knowledge and implications for genetic counselling.
19119171 AXIS inhibition protein 2, orofacial clefts and a family history of cancer.
19219042 Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.
19454617 Genetic variation in the chromosome 17q23 amplicon and breast cancer risk.
19519208 Polygenic susceptibility to breast cancer: current state-of-the-art.
19607694 Low-risk susceptibility alleles in 40 human breast cancer cell lines.
19738052 A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.
19789366 Evaluation of 11 breast cancer susceptibility loci in African-American women.
19931039 Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty.
20054709 Birth weight, breast cancer susceptibility loci, and breast cancer risk.
20056625 Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer.
20056641 Multiple genetic variants in telomere pathway genes and breast cancer risk.
20085711 Leveraging genetic variability across populations for the identification of causal variants.
20126254 Rare variants create synthetic genome-wide associations.
20146796 Familial relative risks for breast cancer by pathological subtype: a population-based cohort study.
20193855 rs2981582 is associated with FGFR2 expression in normal breast.
20237344 Performance of common genetic variants in breast-cancer risk models.
20299982 Evaluating cancer epidemiologic risk factors using multiple primary malignancies.
20364400 Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer.
20453838 Genome-wide association study identifies five new breast cancer susceptibility loci.
20505153 A compendium of genome-wide associations for cancer: critical synopsis and reappraisal.
20530438 Unique SNP in CD44 intron 1 and its role in breast cancer development.
20585100 Genome-wide association studies of cancer.
20699374 Evaluation of breast cancer susceptibility loci in Chinese women.
20718042 Pooled versus individual genotyping in a breast cancer genome-wide association study.
20959865 Genome-wide association of breast cancer: composite likelihood with imputed genotypes.
21037853 Breast cancer in the personal genomics era.
21060860 Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
21203894 Cancer susceptibility variants and the risk of adult glioma in a US case-control study.
21468051 Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.
21497291 Evaluation of nanofluidics technology for high-throughput SNP genotyping in a clinical setting.
21639959 Annual conference on hereditary cancers 2009 szczecin, poland. 10-11 december 2009. Abstracts.
21655367 In search of breast cancer culprits: suspecting the suspected and the unsuspected.
21702935 Genetic variants in the MRPS30 region and postmenopausal breast cancer risk.
21844186 Common breast cancer susceptibility loci are associated with triple-negative breast cancer.
21852243 Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans.
21869864 An integrative genomics approach to biomarker discovery in breast cancer.
22045194 Combined effect of low-penetrant SNPs on breast cancer risk.